Both metabolic syndrome (MetS) and chronic kidney disease (CKD) are major global health issues and are major risk factors for all-cause death and cardiovascular death. Patients with MetS are at a significantly higher risk for CKD. Urinary IgG is an important marker protein for early glomerular damage and increased urinary IgG levels were found to be a useful predictor of diabetic kidney disease in normoalbuminuric patients. We aimed to assess urinary immunoglobulin G (IgG) levels as a predictor of early CKD in subjects with MetS.
(2022). Urinary Immunoglobulin G as A Parameter for Early Detection of Chronic Kidney Disease in Patients with Metabolic Syndrome. Egyptian Society of Diabetes and Lipidology Journal, 2(2), -. doi: 10.21608/esdlj.2022.455815
MLA
. "Urinary Immunoglobulin G as A Parameter for Early Detection of Chronic Kidney Disease in Patients with Metabolic Syndrome", Egyptian Society of Diabetes and Lipidology Journal, 2, 2, 2022, -. doi: 10.21608/esdlj.2022.455815
HARVARD
(2022). 'Urinary Immunoglobulin G as A Parameter for Early Detection of Chronic Kidney Disease in Patients with Metabolic Syndrome', Egyptian Society of Diabetes and Lipidology Journal, 2(2), pp. -. doi: 10.21608/esdlj.2022.455815
VANCOUVER
Urinary Immunoglobulin G as A Parameter for Early Detection of Chronic Kidney Disease in Patients with Metabolic Syndrome. Egyptian Society of Diabetes and Lipidology Journal, 2022; 2(2): -. doi: 10.21608/esdlj.2022.455815
)
